Skip to main content
OpenTrials
Completed

NCT Number: NCT03496350

Internet-delivered Cognitive Behavioural Therapy in Arabic for Anxiety and Depression

The purpose of this study is to evaluate the efficacy of a culturally adapted internet-administrated cognitive behaviour therapy (ICBT) in Arabic for anxiety and depression

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Anxiety Anxiety Disorders Behavior Behavioral Symptoms Depression Mental Disorders

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Linköping University

Linköping, 581 83, Sweden

About this study

The study will compare the effect of the intervention against a wait-list control. The intervention tested is based on cognitive behavior therapy delivered over the internet via a secure treatment platform. Participants in the study are recruited from the general public via social media. The intervention is in Arabic.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Be above 18 years of age
  • Have symptoms of anxiety and/or depression
  • Be able to read and write in Arabic
  • Have access to computer or smartphone

Exclusion criteria

  • Suicidal ideation
  • Alcohol addiction
  • Other major primary psychiatric disorder
  • Ongoing psychological treatment
  • Recent (during last 4 weeks) change in psychiatric medication

Treatment and study plan

Internet-delivered CBT

Behavioral

Culturally adapted transdiagnostic internet-delivered CBT in Arabic

Primary outcomes

  1. Change in Patient Health Questionnaire (PHQ-9)

    Time frame: pre-treatment ,week 3, week 6, week 8 and 12 months post-treatment

    The PHQ-9 is a nine-item self-report questionnaire that measures symptoms of depression. It is scored from 0-27 with a higher score reflecting more severe symptoms.

  2. Change in Generalised Anxiety Disorder-7-item scale, (GAD-7)

    Time frame: pre-treatment ,week 3, week 6, week 8 and 12 months post-treatment

    The GAD-7 is a seven-item self-report questionnaire that measures symptoms of anxiety. It is scored from 0-21 with a higher score reflecting more severe symptoms.

Secondary outcomes

  1. Alcohol Use Disorder Identification Test (AUDIT)

    Time frame: pre-treatment, week 8

    Measures alcohol consumption, drinking behaviors, and alcohol-related problems. It is scored from 0-40 with higher scores reflecting more alcohol consumption, drinking behaviors, and alcohol-related problems.

  2. Insomnia Severity Index (ISI)

    Time frame: pre-treatment, week 8

    Self-reported symptoms of insomnia. It is scored from 0-28 with higher scores reflecting more symptoms of insomnia.

  3. Impact of Events Scale - Revised (IES-R)

    Time frame: pre-treatment, week 8

    Self-reported symptoms of post-traumatic stress. It is scored from 0-88 where higher scores reflect more symptoms.

  4. Perceived Stress Scale (PSS)

    Time frame: pre-treatment, week 8

    Self-reported stress-related symptoms. It is scored from 0-56 with higher scores reflecting more symtoms of perceived stress.

  5. "Brunnsviken Brief Quality of Life Scale" (BBQ)

    Time frame: pre-treatment, week 8

    Self-reported quality of life. The scale is scored from 0-96 with a higher score reflecting higher self-reported quality of life.

Sponsors and collaborators

Lead sponsor

Linkoeping University

Other Gov

Registry information

Official study title

Culturally Adapted Transdiagnostic Internet-delivered Cognitive Behavioural Therapy in Arabic for Anxiety and Depression

Important dates

Study start
2019
Primary completion
2019
Study completion
2019
First posted
Apr 12, 2018
Registry last updated
Feb 20, 2020

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.